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Trustworthy or flawed clinical prediction
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Anders Granholm1, Anders Perner1,2, Aksel Karl Georg Jensen2,3 and Morten Hylander Møller1,2*
See related research by Hilder et al., https://ccforum.biomedcentral.com/articles/10.1186/s13054-017-1888-6.
We read with interest the recently published paper by Hilder
et al. [1], where the authors present the PRESET-Score, a
new clinical prediction rule for patients with acute respira-
tory distress syndrome treated with extracorporeal mem-
brane oxygenation (ECMO). While the topic is clinically
relevant and interesting, we are worried that spurious find-
ings, biased results, and overstated findings are presented.
First, both the new and the four existing scores assessed
are at high risk of being underpowered. Multivariable risk
prediction models should be based on an effective sample
size (lowest number of events/non-events) of at least 10,
often more, per predictor variable assessed [2, 3]. Using 11
variables and 41 non-events (3.7 per predictor) results in
overfitting of the development sample and inflated
performance estimates [2]. This will be evident upon use
of the score in other populations.
Second, comparing the performance of the new score
with four existing scores using the development dataset
is against recommendations [2], as this is biased to favor
the new score due to overfitting. For comparison with
other scores, an independent cohort not used to develop
any of the scores must be used [2].
Third, internal validation is performed to quantify overfit-
ting, and should be done by bootstrap resampling of the de-
velopment dataset [2]. The authors state that they used
logistic regression analysis to “reassess” the score, which
essentially is a recalibration resulting in a new model gener-
ating new predictions. This is neither internal nor external
validation, which requires assessment of predictions made
by the score without modifications in a new sample [2].
Fourth, it is recommended to assess calibration by
graphical methods or regressions of the predicted versus
observed outcomes [2, 4], not by the Hosmer-Lemeshow
Ĉ-test, as P > 0.05 is more likely to indicate lack of power
than proper model fit when used on small samples.
While we agree that clinical prediction rules may be valu-
able for clinicians considering ECMO, it is a prerequisite
that such scores are developed and validated using appro-
priate methodology [2] and sufficient sample sizes, and that
all relevant features are transparently reported with
adequate discussion of the limitations [5]. Developing and
sufficiently validating a clinical prediction rule for this
highly selected patient group likely requires a large, multi-
centre collaboration to ensure trustworthy predictions that
will benefit patients and relatives, the healthcare system,
researchers, and society.
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